Evervie Health Ltd. Share Price

Overview

Evervie Health Ltd. share price is currently ₹43.28, up by ₹1.20 (2.85%) from its previous closing price of ₹42.08. The share price has gained 7.45% over the past month and gained 28.42% over the past year. The stock's 52-week low and high are ₹22.73 and ₹71.19, respectively. Evervie Health Ltd. has a market capitalisation of ₹ 1,109.58 Cr. The share price was last updated on 20 Nov 2026, 10:48 AM IST.

Evervie Health Ltd.
Evervie Health Ltd.
PVP
 ₹0.00
 ₹1.20
2.85%
Realty
 ₹0.00(%)1D

Updated: 20 Nov 2026, 10:48:26 am IST

Market Data

Open Price

 ₹41.80

Prev. Close

 ₹42.08
 ₹40.93

Day Low

 ₹43.96

Day High

 ₹22.73

52 Week Low

 ₹71.19

52 Week High

RealtyConstruction - Real Estate
CategoryMicro Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

160.30

Sector PE

31.32

PB Ratio

5.16

Sector PB

3.32

EPS

0.27

Dividend Yield

0.00

Today's Volume

439.405 K

5 Day Avg. Volume

488.867 K

PEG Ratio

-165.26

Market Cap.

₹ 1,109.58 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Corporate Actions will be available shortly.

Mutual Fund Ownership

Mutual Fund Ownership will be available shortly.

About Evervie Health Ltd. 👋

PVP Ventures Limited is an India-based company, which is engaged in the business of health care services and developing urban infrastructure and investments in various ventures. The Company's segments include Real Estate, Health Care Services and Others. It offers healthcare services across a spectrum of offerings driven entirely through inorganic growth. Its focus areas include cancer care, senior care, teleradiology, dialysis, and diagnostics, including genomics. The Company's brands include Orange Imaging & Diagnostics, DOC Medical Services and Humain Sai Labs. Its subsidiaries include PVP Corporate Parks Private Limited, Safetrunk Services Private Limited, Humain Healthtech Private Limited, Noble Diagnostics Private Limited and Apta Medical Imaging Private Limited.

Analyst Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
Dharmesh Bhatt

Dharmesh Bhatt

20 Oct • 3:08 PM · SEBI-Registered Analyst

Evervie Health Limited : Issues LOI for 10 LINAC Systems

!PVP Evervie Health Limited (formerly known as PVP Ventures Limited) has announced significant business developments aimed at fortifying its strategic pivot toward the healthcare sector. Under the leadership of Chairman and Managing Director Prasad V. Potluri, the company has issued a Letter of Intent (LOI) for high-end medical infrastructure and updated its corporate web identity. Key Transaction Highlights : * Strategic Counterparty: Elekta Solutions AB, Sweden. Asset Procurement: Letter of Intent (LOI) signed for ten (10) HARMONY linear accelerator (LINAC) systems (including software, equipment, accessories, documentation, installation, and commissioning). * Estimated Deal Value: Broadly valued between US$ 11 million to 15 million, with consideration payable in Swedish Krona (SEK) as per the definitive agreement. * Operational Entity: The procured systems are intended to be operated by the company's subsidiary, Optimus Oncology Private Limited. * Deployment Timeline: Phased delivery schedule starting with an initial lot of 5 units followed by the remaining 5, with tentative completion by October 2028. * Corporate Governance & Digital Rebranding HighlightsArm’s Length & Independent: The procurement is an international trade agreement with no promoter or promoter group interest in Elekta Solutions AB, confirming it is not a related-party transaction. * Conditional Agreement Status: The current LOI establishes commercial intent but does not constitute a definitive purchase agreement or legally obligate Elekta to supply until final contracts, statutory approvals, and financial arrangements are executed. * Digital Identity Transition: In alignment with its recent corporate name change from PVP Ventures Limited to Evervie Health Limited, the company has officially launched its new website—***** the legacy domain. Disclosure /Disclaimer Link: *****

See More
Sunil Kotak

Sunil Kotak

19 Aug • 12:21 PM · SEBI-Registered Analyst

Q1FY27 Quarterly Result Announced for PVP Ventures Ltd.

PVP SEBI RA – Shubh Consultancy – Sunil Kotak – INH000015826 Q1FY27 Quarterly Result Announced for PVP Ventures Ltd. Realty company PVP Ventures announced Q1FY27 results Standalone Financial Highlights: Total Income for Q1FY27 stood at Rs 3,892.20 lakh, representing a significant YoY growth of 205.07% from Rs 1,275.85 lakh in Q1FY26 and a QoQ increase of 85.04% from Rs 2,103.43 lakh in Q4FY26. Revenue from operations was reported at Rs 1,349.27 lakh in Q1FY27, reflecting a YoY increase of 46.77% compared to Rs 919.28 lakh in Q1FY26 and a QoQ growth of 27.01% from Rs 1,062.33 lakh in Q4FY26. Other Income surged to Rs 2,542.93 lakh in Q1FY27, up 613.16% YoY from Rs 356.57 lakh in Q1FY26 and 144.25% QoQ from Rs 1,041.10 lakh in Q4FY26. Profit before tax reached Rs 1,496.20 lakh in Q1FY27, a massive growth compared to a profit of Rs 15.38 lakh in Q1FY26 and an increase of 133.50% QoQ from Rs 640.77 lakh in Q4FY26. Net Profit for the quarter stood at Rs 1,511.16 lakh in Q1FY27, marking an increase of 1,832.68% YoY from Rs 78.19 lakh in Q1FY26 and a 147.89% increase QoQ from Rs 609.60 lakh in Q4FY26. Basic Earnings Per Share (EPS) for Q1FY27 improved to Rs 0.58 from Rs 0.03 in Q1FY26. All this is for information This is not a buy/sell recommendation. Thank you, Technofunda24

See More
Umang Bhutada

Umang Bhutada

23 Oct • 9:08 AM · SEBI-Registered Analyst

PVP | TECHNO-FUNDA ANALYSIS

PVP Ventures Ltd – 1D PVP Trend: The stock has witnessed a sharp uptrend followed by a flag pattern consolidation, indicating a healthy pause before a potential continuation move. Price is holding firmly above strong support, showing accumulation at lower levels. Key Levels- Flag Breakout Level: ₹37.00 Strong Support: ₹26.80 Major Support: ₹18.37 Fundamentals (Key Points): 🏗️ Engaged in diversified real estate and media investments. 📉 Revenue volatility persists due to limited business diversification. 💡 Recent positive volume activity hints at possible revival interest. ⚠️ Needs fundamental improvement for sustainable long-term growth. Final Verdict: Bullish Bias — Sustaining above ₹26.80 keeps structure positive; breakout above ₹37 can trigger a strong upward move.

See More
Prachi Mehta

Prachi Mehta

6 May • 9:40 AM · SEBI-Registered Analyst

Stocks to keep an eye today : 6 May 2025

PATELENG (PEL) has been awarded contract valued at Rs 1,318.89 crore by CIDCO for the construction of the Kondhane Dam and its allied works using Roller Compacted Concrete (RCC) Technology. PEL had earlier been declared the L1 (lowest bidder) for this project. The project is located in Village Kondhane, Taluka Karjat, District Raigad in the state of Maharashtra, and is scheduled to be completed within 42 months. !Sattrix Information Security’s wholly owned subsidiary -- Sattrix Information Security Incorporation has received acceptance of an order for Cybersecurity Security Operations Center (SOC) Maintenance Services from West Suburban Medical Center, USA. IRCON has bagged work order worth Rs 187.08 crore (excl. GST) from Kerala State IT Infrastructure for construction of dedicated rural industrial park in Thiruvananthapuram district. The said order is to be executed in 30 months. PARAS and Space Technologies has entered into an MOU (Memorandum of Understanding) on May 05, 2025 with HevenDrones (HD), Israel, with an intent to create new opportunities and expand both parties' business in the Indian and global defence sector. Senores Pharmaceuticals (SPL), through its wholly-owned subsidiary Senores Pharmaceuticals, Inc., USA (SPI), has signed agreement to acquire the USFDA-approved Abbreviated New Drug Application (ANDA) for Topiramate HCl 25, 50, 100 and 200 mg tablets (Topiramate) from Wockhardt. PVP Ventures has acquired 46,70,761 Equity Shares in Optimus Oncology by paying the total consideration amount of Rs 54.73 crore. Optimus Oncology becomes the subsidiary of PVP Ventures with effect from May 05, 2025. CYIENT 's wholly owned subsidiary, Cyient Inc., located in the US, has received an order levying a penalty of $26,779.74 from the Department of the Treasury, Internal Revenue Service (IRS), USA, for the penalty towards employer shared responsibility payment (ESRP).

See More

News & Events

Frequently Asked Questions

What is the share price of Evervie Health Ltd.?

What is the market cap of Evervie Health Ltd.?

Should I buy Evervie Health Ltd. stock now?

What is the 52 week high and low of Evervie Health Ltd.?

Is the Evervie Health Ltd. stock good to buy?

Is Evervie Health Ltd. a good buy for the long term?

Is Evervie Health Ltd. overvalued or undervalued?

What is the PE and PB ratio of Evervie Health Ltd.?

Start Now